Human activities release more carbon dioxide (CO₂) into the atmosphere than the natural process can remove. This study attempts to address the main challenges for the thermophilic (50 °C) bioelectrochemical conversion of CO₂ into acetate. First, real gaseous emissions were tested with mixed microbial consortia, which had no substantial influence on production rates (difference of 2.5%). Subsequently, a bench-scale system (TRL 4-5) was designed and launched to control key operational variables. Fixing the current at 1.3 A m⁻², CO₂ was reduced at a rate of 2.21 kg CO₂ kg⁻¹ acetate, while the electricity consumption was 2.07 kWh kg⁻¹, the most efficient value so far. The results suggest that the operation with real effluents is feasible and the proposed design is energy efficient, but the right balance between maximising current densities without compromising the biocompatibility with catalysts will determine the transition from laboratory scale towards its implementation in the market.
No takes yet. Share an insight, caveat, or question.
Rovira-Alsina et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: